Growth of zero-premium Medicare Advantage plans in counties with high cancer mortality

View at publisher
Authors: Changchuan Jiang, Lesi He, C. Y. Lu, Ryan D Nipp, K Robin Yabroff, Xuesong Han, Xin Hu, Joshua M. Liao
Cited by: 3
References: 32

Abstract

BACKGROUND: Zero-premium Medicare Advantage (MA) plans have rapidly become the most popular MA plan type in the United States, despite potentially restrictive benefit design. It remains unclear whether the growth of these plans aligns with the county-level cancer mortality. METHODS: We conducted a 2-part, county-level ecological study. First, using Centers for Medicare & Medicaid Services (CMS) enrollment data (2019-2024) and National Center for Health Statistics (NCHS) mortality data (2018-2022), we examined longitudinal trends in the market share of zero-premium MA plans overall and across counties by their cancer-mortality rate quartiles. Second, we performed a cross-sectional, mixed-effects logistic regression analysis of 2019-2024 plan-level data to evaluate the association between zero-premium MA and low plan quality (

Fields of Study & Subjects

Economic and Financial Impacts of Cancer Healthcare Policy and Management Health Systems Economic Evaluations Quality of Life

Publication details

Journal / source
JNCI Journal of the National Cancer Institute
Publisher
Oxford University Press (OUP)
Volume
118
Issue
6
Pages
997–1005
Publication date
7 January 2026
Language
EN